ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2019

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus.

Christopher G Fawsitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.